152 related articles for article (PubMed ID: 27119113)
1. Development of new therapy for canine mammary cancer with recombinant measles virus.
Shoji K; Yoneda M; Fujiyuki T; Amagai Y; Tanaka A; Matsuda A; Ogihara K; Naya Y; Ikeda F; Matsuda H; Sato H; Kai C
Mol Ther Oncolytics; 2016; 3():15022. PubMed ID: 27119113
[TBL] [Abstract][Full Text] [Related]
2. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.
Sugiyama T; Yoneda M; Kuraishi T; Hattori S; Inoue Y; Sato H; Kai C
Gene Ther; 2013 Mar; 20(3):338-47. PubMed ID: 22717740
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor activity of a recombinant measles virus against canine lung cancer cells.
Tamura K; Fujiyuki T; Moritoh K; Akimoto H; Iizuka K; Sato H; Asano K; Yoneda M; Kai C
Sci Rep; 2023 Oct; 13(1):18168. PubMed ID: 37875555
[TBL] [Abstract][Full Text] [Related]
4. Recombinant SLAMblind Measles Virus Is a Promising Candidate for Nectin-4-Positive Triple Negative Breast Cancer Therapy.
Fujiyuki T; Amagai Y; Shoji K; Kuraishi T; Sugai A; Awano M; Sato H; Hattori S; Yoneda M; Kai C
Mol Ther Oncolytics; 2020 Dec; 19():127-135. PubMed ID: 33145396
[TBL] [Abstract][Full Text] [Related]
5. A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells.
Fujiyuki T; Yoneda M; Amagai Y; Obayashi K; Ikeda F; Shoji K; Murakami Y; Sato H; Kai C
Oncotarget; 2015 Sep; 6(28):24895-903. PubMed ID: 26317644
[TBL] [Abstract][Full Text] [Related]
6. Measles virus selectively blind to signaling lymphocyte activity molecule has oncolytic efficacy against nectin-4-expressing pancreatic cancer cells.
Awano M; Fujiyuki T; Shoji K; Amagai Y; Murakami Y; Furukawa Y; Sato H; Yoneda M; Kai C
Cancer Sci; 2016 Nov; 107(11):1647-1652. PubMed ID: 27561180
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of an oncolytic measles virus against canine urinary bladder transitional cell carcinoma cells.
Iizuka K; Shoji K; Fujiyuki T; Moritoh K; Tamura K; Yoshida A; Sato H; Yoneda M; Asano K; Kai C
Res Vet Sci; 2020 Dec; 133():313-317. PubMed ID: 33183781
[TBL] [Abstract][Full Text] [Related]
8. Immune response elicited in the tumor microenvironment upon rMV-SLAMblind cancer virotherapy.
Moritoh K; Shoji K; Amagai Y; Fujiyuki T; Sato H; Yoneda M; Kai C
Cancer Sci; 2023 May; 114(5):2158-2168. PubMed ID: 36715555
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic Activity of a Recombinant Measles Virus, Blind to Signaling Lymphocyte Activation Molecule, Against Colorectal Cancer Cells.
Amagai Y; Fujiyuki T; Yoneda M; Shoji K; Furukawa Y; Sato H; Kai C
Sci Rep; 2016 Apr; 6():24572. PubMed ID: 27090874
[TBL] [Abstract][Full Text] [Related]
10. Recombinant measles virus vaccine rMV-Hu191 exerts an oncolytic effect on esophageal squamous cell carcinoma via caspase-3/GSDME-mediated pyroptosis.
Wu A; Li Z; Wang Y; Chen Y; Peng J; Zhu M; Li Y; Song H; Zhou D; Zhang C; Lv Y; Zhao Z
Cell Death Discov; 2023 May; 9(1):171. PubMed ID: 37202386
[TBL] [Abstract][Full Text] [Related]
11. A recombinant Chinese measles virus vaccine strain rMV-Hu191 inhibits human colorectal cancer growth through inducing autophagy and apoptosis regulating by PI3K/AKT pathway.
Zhang CD; Wang YL; Zhou DM; Zhu MY; Lv Y; Hao XQ; Qu CF; Chen Y; Gu WZ; Wu BQ; Chen PC; Zhao ZY
Transl Oncol; 2021 Jul; 14(7):101091. PubMed ID: 33848808
[TBL] [Abstract][Full Text] [Related]
12. A recombinant measles virus vaccine strain rMV-Hu191 has oncolytic effect against human gastric cancer by inducing apoptotic cell death requiring integrity of lipid raft microdomains.
Lv Y; Zhou D; Hao XQ; Zhu MY; Zhang CD; Zhou DM; Wang JH; Liu RX; Wang YL; Gu WZ; Shen HQ; Chen X; Zhao ZY
Cancer Lett; 2019 Sep; 460():108-118. PubMed ID: 31226409
[TBL] [Abstract][Full Text] [Related]
13. Recombinant measles virus induces cytolysis of cutaneous T-cell lymphoma in vitro and in vivo.
Künzi V; Oberholzer PA; Heinzerling L; Dummer R; Naim HY
J Invest Dermatol; 2006 Nov; 126(11):2525-32. PubMed ID: 16960554
[TBL] [Abstract][Full Text] [Related]
14. Combination of Oncolytic Measles Virus Armed With BNiP3, a Pro-apoptotic Gene and Paclitaxel Induces Breast Cancer Cell Death.
Lal G; Rajala MS
Front Oncol; 2018; 8():676. PubMed ID: 30697531
[TBL] [Abstract][Full Text] [Related]
15. Canine Distemper Virus Spread and Transmission to Naive Ferrets: Selective Pressure on Signaling Lymphocyte Activation Molecule-Dependent Entry.
Sawatsky B; Cattaneo R; von Messling V
J Virol; 2018 Aug; 92(15):. PubMed ID: 29793948
[TBL] [Abstract][Full Text] [Related]
16. The Host Cell Receptors for Measles Virus and Their Interaction with the Viral Hemagglutinin (H) Protein.
Lin LT; Richardson CD
Viruses; 2016 Sep; 8(9):. PubMed ID: 27657109
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors.
Saito T; Tamura D; Asano R
Oncol Rep; 2014 Apr; 31(4):1637-44. PubMed ID: 24503782
[TBL] [Abstract][Full Text] [Related]
18. SLAM- and nectin-4-independent noncytolytic spread of canine distemper virus in astrocytes.
Alves L; Khosravi M; Avila M; Ader-Ebert N; Bringolf F; Zurbriggen A; Vandevelde M; Plattet P
J Virol; 2015 May; 89(10):5724-33. PubMed ID: 25787275
[TBL] [Abstract][Full Text] [Related]
19. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent.
Gentschev I; Stritzker J; Hofmann E; Weibel S; Yu YA; Chen N; Zhang Q; Bullerdiek J; Nolte I; Szalay AA
Cancer Gene Ther; 2009 Apr; 16(4):320-8. PubMed ID: 18949014
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer.
Béguin J; Foloppe J; Maurey C; Laloy E; Hortelano J; Nourtier V; Pichon C; Cochin S; Cordier P; Huet H; Quemeneur E; Klonjkowski B; Erbs P
Mol Ther Oncolytics; 2020 Dec; 19():57-66. PubMed ID: 33072863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
